CTRI/2018/10/016215Not yet recruiting未知
An observation study to assess safety and efficacy of Tablet NGfenceTM 2.6/6.4 mg (Controlled Release) in patients with Angina
Care Lifescience Private Limited0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •1Patients with Normal Sinus Rhythm on ECG at Screening
- •2Patients who have signed Written Informed Consent
- •3Patients with stable/unstable or Prinzmetals angina for at least 3 months prior to inclusion (mild/moderate/severe)
- •4Male or Female patients > 18 years and < 75 years of age.
Exclusion Criteria
- •1Male or Female patients < 18 years and > 75 years of age
- •2Congestive heart failure stage III or IV NYHA.
- •3Symptomatic hypotension.
- •4Atrial fibrillation, flutter, pacemaker or cardioverter-defibrillator implantation
- •5History of serious abnormal drug reaction.
- •6Patients with Postural hypotension
- •7Patients with chronic kidney failure
- •8History of any serious infectious disease like Hepatitis B or C, HIV etc.
- •9History of severe psychiatric or behavioral disorders likely to interfere with the study.
- •10Patients with other severe disease likely to interfere with the study in the investigators judgment.
- •11Pregnant and lactating women.
Investigators
Similar Trials
Not yet recruiting
Phase 2
Study to assess safety and efficacy of Inj Sepsivac in patients of Covid-19CTRI/2020/05/025350R D Gardi Medical College
Not yet recruiting
Unknown
Observational study to find out efficacy and safety of Bifidobacterium longum W11 plus Fructooligosaccharide combination in patients with irritable bowel syndromeCTRI/2024/07/070510Abbott India Ltd
Recruiting
Unknown
Observational study on HAL lower limb model, non medical for non-acute strokeon-acute strokeStroke, non-acute, gait disturbanceD020521JPRN-jRCT1030220498akajima Takashi10
Recruiting
Unknown
An observational study of the safety and efficacy of nivolumab as adjuvant treatment for esophageal cancer using the Comprehensive Registry of Esophageal Cancer in the National Clinical Database.Esophageal cancer or esophagogastric cancerJPRN-UMIN000050925Japanese Foundation For Cancer Research1,750
Not yet recruiting
Phase 3
COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF 10% RETINOL PEEL AND 70% GLYCOLIC ACID PEEL IN THE TREATMENT OF ACANTHOSIS NIGRICANSCTRI/2023/09/057674CHERUKUPALLI ANANTH